SPONSOR
Shanghai Jiao Tong University School of Medicine
Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 2, Phase 3, EARLY_Phase 1, Phase 1, Phase 3
Conditions studied: Breast CancerB-Cell Lymphoblastic LeukemiaHyperchylomicronemiaComplicated Adrenal Tumor DiseasesRecurrent Non-small Cell Lung CancerConfocal EnteroscopyQuality Assessment SystemStandardized ImplementationAtrophic GastritisAdrenal Cortical Carcinoma
Shanghai Jiao Tong University School of Medicine is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Breast Cancer, B-Cell Lymphoblastic Leukemia, Hyperchylomicronemia, Complicated Adrenal Tumor Diseases.
The trial portfolio spans Phase 2, Phase 2, Phase 3, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Jiao Tong University School of Medicine
How many clinical trials has Shanghai Jiao Tong University School of Medicine sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Shanghai Jiao Tong University School of Medicine, of which 13 are actively recruiting participants. These trials cover conditions including Breast Cancer, B-Cell Lymphoblastic Leukemia, Hyperchylomicronemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Jiao Tong University School of Medicine research focus on?
Shanghai Jiao Tong University School of Medicine clinical trials span Breast Cancer, B-Cell Lymphoblastic Leukemia, Hyperchylomicronemia, Complicated Adrenal Tumor Diseases, Recurrent Non-small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Jiao Tong University School of Medicine clinical trial?
To participate in a Shanghai Jiao Tong University School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Jiao Tong University School of Medicine trials with current recruitment status updated daily.
Clinical Trials by Shanghai Jiao Tong University School of Medicine
NCT06500208 Phase 2
Recruiting
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
Breast Cancer
NCT06607419 Phase 2, Phase 3
Recruiting
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
B-Cell Lymphoblastic Leukemia
NCT07371767 EARLY_Phase 1
Recruiting
CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
Hyperchylomicronemia
NCT04529629
Recruiting
Precise Diagnosis, Treatment and Prognostic Evaluation of Complicated Adrenal Tumor Diseases
Complicated Adrenal Tumor Diseases
NCT02889666 Phase 1
Recruiting
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Recurrent Non-small Cell Lung Cancer
NCT07363291
Recruiting
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
Confocal Enteroscopy
NCT07371208 Phase 2
Recruiting
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer
Breast Cancer
NCT06203327
Recruiting
Atrophic Gastritis Predicts the Risk of Gastric Cancer
Atrophic Gastritis
NCT06141369
Recruiting
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Adrenal Cortical Carcinoma
NCT06705062 Phase 3
Recruiting
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Allogeneic Hematopoietic Cell Transplant
NCT04113070
Recruiting
Overweight and Obesity and Puberty Development Cohort Study
Precocious Puberty
NCT05765981 EARLY_Phase 1
Recruiting
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
NCT07799831
Recruiting
Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study.
Juvenile Idiopathic Arthritis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology